Following our participation in National NSF I-Corps, NeuroSentry was selected for the NSF I-Corps AccelCorps Minimum Viable Product Development and Testing Pilot.
More than 70 National I-Corps teams applied, with 18 selected to participate.
Where National I-Corps focused heavily on customer discovery, the AccelCorps program provided an opportunity to move toward customer validation—engaging prospective users, testing product assumptions, and translating what we learned from the market into MVP development.
For NeuroSentry, this represented another step toward converting clinical need and customer insight into a product designed for real-world hospital workflows.
More Details on the Program: https://giesbusiness.illinois.edu/news/2024/04/22/gies-professor-launches-accelcorps--to-bridge-stem-and-business
